Funder
office of academic affairs advanced fellowship in health services research, department of veterans affairs
agency for healthcare research and quality
national institute of diabetes and digestive and kidney diseases
knight-hennessy scholars, stanford university
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data [Internet]. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2019. Accessed 30 Dec 2021 from: https://www.cdc.gov/nchs/nhanes/index.htm
2. United States Renal Data System. 2019 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2019.
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med. 2004 Sep 23;351(13):1296–305.
4. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. The Lancet. 1999 Jul;354(9176):359–64.
5. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving H-H, et al. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. N Engl J Med. 2001 Sep 20;345(12):861–9.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献